CDSCO Drug Import Licence Consultant in India helps pharmaceutical companies, drug importers, distributors, foreign manufacturers, Indian authorised agents, API importers, formulation companies, healthcare businesses, and overseas pharmaceutical brands planning to import drugs into the Indian market.

Import of human-use bulk drugs and finished pharmaceutical formulations into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940 and Drugs Rules, 1945. CDSCO's revised import guidance, effective August 4, 2026, confirms that the Import & Registration Division handles registration and import licensing for bulk drugs or APIs and finished formulations.

Importing a pharmaceutical product involves more than arranging an overseas shipment. The foreign manufacturing site and proposed drugs may first need registration, the Indian importer or authorised agent must satisfy licensing requirements, product documentation and labels must comply with applicable rules, and the required CDSCO import licence must be obtained before commercial import.

A CDSCO Drug Import Licence Consultant assists businesses with applicability assessment, foreign manufacturing-site registration, document review, Form 41 Registration Certificate support, Form 10 or Form 10A import licensing, SUGAM filing, new drug permission coordination, label review, CDSCO query response, and post-approval compliance.

What is a CDSCO Drug Import Licence?

A CDSCO Drug Import Licence is the regulatory licence that permits eligible drugs manufactured outside India to be imported into the country.

Under CDSCO's current guidance:

• Form 10 is the import licence for drugs other than those specified in Schedule X.
• Form 10A is the import licence for drugs covered under Schedule X.
• Form 8 is used to apply for an import licence for drugs other than Schedule X drugs.
• Form 8A is used for Schedule X drugs.

The appropriate route depends on the drug category and regulatory status of the proposed product.

Which Drugs May Require CDSCO Import Licence?

CDSCO's current Import & Registration framework covers human-use:

• Bulk drugs
• Active Pharmaceutical Ingredients
• Finished formulations
• Pharmaceutical products manufactured outside India

CDSCO states that drugs falling within the applicable definition require registration before import and that the foreign manufacturing site is also required to be registered for import into India.

Additional requirements may apply where the product qualifies as a new drug under the New Drugs and Clinical Trials Rules, 2019.

Registration Certificate and Import Licence – What is the Difference?

Importers often confuse the Registration Certificate with the Import Licence.

A Registration Certificate in Form 41 registers the foreign manufacturing premises and the drugs manufactured at that site for import into India.

The application for Registration Certificate is made through Form 40 on the CDSCO SUGAM portal.

An Import Licence in Form 10 or Form 10A permits the approved product to actually be imported into India.

CDSCO's August 2026 guidance confirms that applications for both Registration Certificates and Import Licences are submitted online through the SUGAM system.

In many cases, therefore, the compliance sequence involves:

Foreign Manufacturing Site Registration → Drug Registration → Form 41 Registration Certificate → Import Licence Application → Form 10/10A → Commercial Import

Who Can Apply for CDSCO Drug Import Licence?

Applications may be handled through an eligible Indian authorised agent or importer.

CDSCO's current guidance states that an Indian authorised agent of the foreign manufacturer should hold an appropriate manufacturing or sale licence. The foreign manufacturer may also apply where it holds the required wholesale licence in India.

This makes proper appointment of the Indian authorised agent an important part of pharmaceutical import planning.

Role of CDSCO Drug Import Licence Consultant

A CDSCO Drug Import Licence Consultant can assist with:

• Drug import applicability assessment
• Product regulatory classification
• Foreign manufacturer documentation review
• Indian authorised agent requirements
• Form 40 registration support
• Form 41 Registration Certificate support
• Form 8 or Form 8A preparation
• Form 9 undertaking
• Form 10 or Form 10A Import Licence support
• SUGAM application filing
• Label compliance review
• New drug permission review
• Power of Attorney documentation
• CDSCO query response
• Product endorsement support
• Post Approval Change applications
• Import licence renewal or fresh application planning
• Ongoing regulatory advisory

The objective is to ensure that the foreign manufacturer, Indian importer, product documentation, and regulatory approvals are aligned before import.

Documents Required for CDSCO Drug Import Licence

CDSCO's revised 2026 guidance provides a specific checklist for an Import Licence application.

Common requirements include:

• Covering letter
• Valid wholesale or manufacturing licence with approved product list
• Valid Form 41 Registration Certificate
• New Drug Permission, where applicable
• Original or specimen product labels
• Duly completed Form 8 or Form 8A
• Form 9 undertaking
• Applicable fee payment proof
• Compliance with conditions specified in the Registration Certificate, if any

Documents should be reviewed carefully because inconsistencies between the Registration Certificate, product name, manufacturer details, licence, and labels may result in regulatory queries.

Documents for Foreign Manufacturing Site Registration

Before obtaining the import licence, foreign manufacturing-site registration may involve a larger technical dossier.

Depending on the application, CDSCO's current checklist includes documents and information such as:

• Covering letter
• Power of Attorney
• Form 40
• Wholesale or manufacturing licence of Indian agent
• Schedule D(I)
• Schedule D(II)
• Plant Master File
• Manufacturing process information
• Product specifications
• Process validation information
• Stability data
• GMP Certificate
• Certificate of Pharmaceutical Product
• Free Sale Certificate
• Product labels and package insert
• Testing information
• Fee payment documentation

Foreign manufacturers should therefore prepare the registration dossier well before planning commercial shipments to India.

CDSCO Drug Import Licence Process

The drug import licensing process can generally be understood in the following stages.

Step 1: Check Product Regulatory Status

The first step is identifying:

• Drug name
• Dosage form
• Strength
• API or finished formulation
• Schedule classification
• New drug status
• Manufacturing site
• Country of origin
• Proposed Indian importer

This determines the applicable regulatory route.

Step 2: Appoint Indian Authorised Agent

Where required, the foreign manufacturer appoints an eligible Indian authorised agent.

The Power of Attorney and related authorisation documents should correctly identify the foreign manufacturer, manufacturing site, Indian agent, and proposed drugs.

CDSCO's current guidance specifies requirements for authentication of the Power of Attorney and also recognises apostilled documents from Hague Convention member countries.

Step 3: Obtain Registration Certificate

The foreign manufacturing premises and proposed drugs are registered through the CDSCO process.

The applicant submits Form 40 and supporting documents through SUGAM.

After review and approval, CDSCO issues the Registration Certificate in Form 41 covering the registered foreign manufacturing site and approved drugs.

Step 4: Obtain New Drug Permission, Where Applicable

If the proposed product falls under the definition of a new drug, the required new drug approval must be obtained before the applicable registration or import process.

CDSCO's 2026 guidance identifies new drug approval as a prerequisite where applicable under the New Drugs and Clinical Trials Rules, 2019.

Step 5: Prepare Import Licence Application

Once the required Registration Certificate and product approvals are available, the import licence application is prepared.

The applicant files:

• Form 8 for drugs other than Schedule X; or
• Form 8A for Schedule X drugs.

A Form 9 undertaking and supporting licensing, registration, label, and fee documents are also submitted.

Step 6: File Application on SUGAM

CDSCO requires Registration Certificate and Import Licence applications to be filed through its online SUGAM portal.

The application is reviewed by CDSCO and queries may be issued if documentation or regulatory information requires clarification.

Step 7: Respond to CDSCO Queries

Common queries may relate to:

• Product name mismatch
• Manufacturer information
• Registration Certificate
• Wholesale licence
• New drug status
• Labels
• Form 8/8A
• Form 9
• Product permissions
• Supporting technical documentation

Responses should directly address every regulatory observation with appropriate supporting documents.

Step 8: Grant of Import Licence

After satisfactory review, the Licensing Authority may issue the applicable Import Licence.

The licence allows the approved products to be imported subject to the licence conditions and applicable regulatory requirements.

CDSCO Import Licence Fees

According to CDSCO's revised guidance effective August 2026, the prescribed import licence fee is:

• ₹10,000 for one drug
• ₹1,000 for each additional drug

The fee is paid through Bharat Kosh and the payment receipt is uploaded with the application on SUGAM.

Fees for foreign manufacturing-site and drug Registration Certificates are separate from these Import Licence fees.

Validity of CDSCO Drug Import Licence

CDSCO's current guidance states that the Import Licence remains valid from its date of issue until the period indicated in the corresponding Registration Certificate, unless suspended or cancelled earlier.

The guidance also provides that where an application for a fresh licence is made three months before expiry of the existing licence, the existing licence may continue until an order is passed on the fresh application.

Importers should therefore monitor both Registration Certificate and Import Licence timelines.

Drug Label Requirements for Imported Products

Imported drug labels must comply with applicable requirements under the Drugs Rules.

CDSCO's 2026 guidance requires original or specimen labels for bulk drugs and finished formulations to comply with Rules 96 and 97, as applicable.

For APIs, the current guidance specifically notes the requirement for a readable QR code in accordance with Rule 96.

Labels should therefore be reviewed before commercial production or shipment.

CDSCO Import Licence for New Drugs

New drugs require additional regulatory attention.

Where a product falls within the applicable new drug definition, the importer should check whether approval under the New Drugs and Clinical Trials Rules, 2019 is required before registration or import.

CDSCO's current import checklist specifically requires the applicable new drug permission to be submitted with the Import Licence application.

Businesses should therefore establish the product's regulatory status before beginning the import registration process.

Post Approval Changes for Imported Drugs

Regulatory work does not necessarily end after the Registration Certificate and Import Licence are issued.

Changes may require a Post Approval Change (PAC) application.

CDSCO's 2026 guidance identifies changes such as manufacturing-process modifications, testing-method changes, shelf-life changes, storage-condition changes, certain manufacturer name or address changes, and addition or deletion of manufacturing sites as examples that may require regulatory action.

Importers should therefore review CDSCO requirements before implementing major changes relating to the registered product or manufacturing site.

Common Mistakes in CDSCO Drug Import Licence Applications

Common problems include:

• Applying before registering the foreign manufacturing site
• Missing Form 41 Registration Certificate
• Incorrect Form 8 or Form 8A
• Incomplete Form 9
• Product name mismatch
• Manufacturer address mismatch
• Missing new drug permission
• Incorrect product labels
• Expired wholesale licence
• Incomplete Power of Attorney
• Missing regulatory certificates
• Not fulfilling conditions mentioned in the Registration Certificate
• Poorly organised technical documentation
• Delayed response to CDSCO queries

A pre-submission regulatory review can reduce avoidable objections.

Benefits of Hiring CDSCO Drug Import Licence Consultant

Professional CDSCO consulting can help pharmaceutical importers with:

• Correct regulatory pathway assessment
• Foreign manufacturer registration
• Documentation review
• SUGAM application filing
• Form 41 support
• Form 10/10A licensing support
• New drug compliance coordination
• Label review
• Query response
• Post Approval Change support
• Renewal planning
• Ongoing drug import compliance

This can be particularly useful for foreign pharmaceutical manufacturers entering India for the first time.

Why Choose Green Permits for CDSCO Drug Import Licence?

Green Permits Consulting supports importers, manufacturers, overseas brands, and businesses with regulatory registrations and market-entry compliance in India.

Green Permits can assist with:

• CDSCO Drug Import Licence
• Drug Registration Certificate support
• Foreign manufacturer registration
• SUGAM application support
• Documentation review
• New drug regulatory assessment
• Product label review
• Query response
• Post Approval Changes
• Other import and product compliance requirements

The objective is to help pharmaceutical companies build a clear compliance pathway before importing and marketing regulated products in India.

Learn More About CDSCO Drug Import Licence Consultant in India

If your company plans to import APIs, bulk drugs, or finished pharmaceutical formulations into India, CDSCO registration and import licensing should be completed before shipment. Proper planning ensures the manufacturing site, products, importer, labels, and documents meet all requirements.

Read more about CDSCO registration here:
👉 https://www.greenpermits.in/08/cdsco-drug-import-licence-consultant-pharma-india/

📞 Get Expert Assistance for CDSCO Drug Import Licence

If you need help with CDSCO Drug Import Licence in India, Form 41 Registration Certificate, Form 10/10A Import Licence, SUGAM filing, new drug regulatory requirements, documentation, or CDSCO query response, Green Permits Consulting can assist you.

🌐 Website: https://www.greenpermits.in/

📞 Phone: +91 78350 06182

📧 Email: wecare@greenpermits.in

Book a consultation with Green Permits Consulting for CDSCO Drug Import Licence and pharmaceutical import compliance support in India.